Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) (DeLOS II)
This study is currently recruiting participants.
Verified August 2010 by University of Leipzig
Sponsor:
University of Leipzig
Collaborators:
Merck
Sanofi
Information provided by:
University of Leipzig
ClinicalTrials.gov Identifier:
NCT00508664
First received: July 27, 2007
Last updated: August 4, 2011
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |